With the analysis among 148 patents, we discovered top 40 key players by total patent application. Roche Innovation Center Copenhagen A/S, Santaris Pharmaceuticals A/S, Monsanto Technology LLC are dominant in this area. They take 37.84% of the total patent filing.
Roche Innovation Center Copenhagen A/S
Hovedstaden, Denmark
Patent: 23
Santaris Pharmaceuticals A/S
Missouri, United States
Patent: 14
VIROGIN BIOTECH CANADA LTD.
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 12
California, United States
Patent: 8
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Delaware, United States
Patent: 5
Pioneer Hi-Bred International, Inc.
Iowa, United States
Patent: 5
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 5
With the analysis among 23 patents, we discovered top 5 start-ups by total patent application. Combined Therapeutics, Inc., Shenzhen Immvira Pharma Co., Ltd., Karydo TherapeutiX, Inc. are active in this area.
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 5
Eclipse Bioinnovations, Inc.
California, United States
Patent: 2
Institut National de la Santé et de la Recherche Médicale
With the analysis among related 103 patents applied in the last 5 years. We discover 47 most active companies in this area. The fast-growing TRUSTEES OF THE UNIV OF PENNSYLVANIA, VIROGIN BIOTECH CANADA LTD., Combined Therapeutics, Inc. take 39.81% of patent filing during this period.
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 16
VIROGIN BIOTECH CANADA LTD.
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 5
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 5
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Nanjing University of Posts & Telecommunications
Jiangsu Sheng, China
Patent: 2
The Children's Hospital of Philadelphia
Pennsylvania, United States
Patent: 2
Guangdong Sheng, China
Patent: 2
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 2
With the analysis among related 103 patents in last 5 years, we discover 39 new entrants. TRUSTEES OF THE UNIV OF PENNSYLVANIA, VIROGIN BIOTECH CANADA LTD., Combined Therapeutics, Inc. are the most active new entrants in this area.
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 16
VIROGIN BIOTECH CANADA LTD.
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 5
Nanjing University of Posts & Telecommunications
Jiangsu Sheng, China
Patent: 2
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 2
Yunnan Sheng, China
Patent: 2
Hefei Institutes of Physical Science
Anhui Sheng, China
Patent: 2
Consejo Superior de Investigaciones Científicas
Eclipse Bioinnovations, Inc.
California, United States
Patent: 2
With the analysis among 118 patents, we discovered top 40 universities and scientific research institutions by total patent application. Council of Scientific & Industrial Research, King's College London, Ruprecht-Karls-Universität Heidelberg are dominant in this area. They take 28.81% of the total patent filing.
Council of Scientific & Industrial Research
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 6
Guangdong Sheng, China
Patent: 4
University of South Florida
The Shenzhen Institutes of Advanced Technology
Shanghai Shi, China
Patent: 3
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 2
Swiss Federal Institute of Technology Zurich
ZURICH, Switzerland
Patent: 2
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 2